Under the guidance of Professor of Chemistry and Center for Computational Biology (CCIB) faculty member Jinglin Fu, Rutgers–Camden students are benefiting from a grant of almost $500,000 from the National Institutes of Health (NIH). The goal of the research is to produce a new nucleic acid nanoparticle-based delivery system for the genome editing of blood stem cells. Successful completion of this ongoing research will potentially revolutionize the treatment of various genetic disorders, such as sickle cell anemia. Genome editing involves the alteration of the genetic material of a living organism by inserting, replacing, or deleting a DNA sequence, typically aiming to improve or correct a genetic disorder. This kind of research can influence future studies and clinical applications of stem cells in regenerative medicine, which will contribute to the broader field of genetic medicine while also engaging the potential of emerging scientists. To read the full story.